Evidence map›Paper›PMID 42609835›Full record

ArticleCJC open2026

From Lived Experiences to Systemic Change: Patient Perspectives on the Diagnostic Journey of Loeys-Dietz Syndrome.

Sally Al-Mufty, Michael P Mackley, Lindsay Parsons, Susan Randall Armel, Jeanna McCuaig, David Chitayat, Samantha Afonso

Abstract read
In one paragraph

Article in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sally Al-MuftyDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Michael P MackleyDivision of Clinical and Metabolic Genetics, Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
Lindsay ParsonsLoeys-Dietz Syndrome Foundation Canada, Pointe-Claire, Quebec, Canada.
Susan Randall ArmelDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Jeanna McCuaigDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
David ChitayatDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Samantha AfonsoDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Loeys-Dietz syndrome (LDS) is a rare genetic connective tissue disorder characterized by early-onset aortic aneurysms and dissections, making early diagnosis crucial for patients' survival. Due to its rarity and overlap with other conditions, LDS is often challenging to diagnose. This study explored the diagnostic experiences of Canadians with LDS to identify perceived barriers, supports, and patient-informed gaps for improving diagnosis and care. Methods: In-depth semi-structured interviews were conducted with 9 adults across Canada who were the first in their family to receive a confirmed diagnosis of LDS. Transcripts were generated, reviewed for accuracy, de-identified, and analyzed thematically using an inductive approach with iterative coding and team-based consensus around themes. Results: Five themes emerged: (i) patient role-individuals demonstrated self-advocacy and persistence; (ii) clinician role-clinicians acted as either catalysts or constraints; (iii) system role-healthcare was perceived as reactive and unequal, with limited consistency; (iv) impact of diagnosis-receiving a diagnosis of LDS brought clarity but also emotional challenges; and (v) patient-identified gaps-participants recognized challenges and emphasized enhanced education, proactive detection, ongoing support, and centralized care pathways to improve the diagnostic journey. Conclusions: The timeliness and accuracy of LDS diagnosis are shaped by interactions among patient persistence, clinician awareness, and coordination, with delays driven by limited knowledge, fragmented care, and system barriers, despite the life-threatening risk involved. Patients identified gaps in clinician awareness, diagnostic pathways, psychosocial support, and care coordination. These findings emphasize cardiologists' central role in integrated multidisciplinary cardiology-genetics models to improve timely care and recognition of rare cardiovascular conditions.

Indexed as

aortic diseasesconnective tissue diseasesdiagnosisgenetic testingpatient advocacyqualitative researchrare disease

Identifiers

PMID42609835
PMCPMC13480217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.